跳至主要内容
临床试验/JPRN-UMIN000010071
JPRN-UMIN000010071已完成未知

Drug Eluting stent implantation vs BAre metal sTEnt implantation in treatment of SFA - DEBATE in SFA

Shinshu university hospital0 个研究点目标入组 360 人开始时间: 2013年2月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 99years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Exclusion criteria Patient criteria Patients who meet any of the following criteria should be excluded from the study: 1.Patients with or at risk of hemorrhagic complications or patients with bleeding* tendency *Bleeding such as hemophilia, capillary fragility, intracranial hemorrhage, gastrointestinal hemorrhage, urinary tract hemorrhage, hemoptysis, or vitreous hemorrhage may be aggravated. 2.Patients with congestive cardiac failure (NYHA III or IV or EF<30%) 3.Patients implanted a drug-eluting stent (DES) within 3months 4.patients with a history of serious adverse reaction such as leukopenia, hepatic dysfunction, or renal dysfunction, or hypersensitivity to any component of the study drug. 5.Pregnant or potentially pregnant women 6.Patients with acute lower limb ischemia 7.Patients who are not eligible for the study in the opinion of the attending physician. Lesion criteria Lesions that meet any of the following criteria should be excluded from the study: 1.Remnant inflow (aorta-iliac artery lesion) 2.Severe calcification (lesions not expected to be appropriately expanded)

研究者

相似试验